Superior mesenteric venous thrombosis due to prothrombin 20210 G/A and MTHFR C677T mutations: Case report
Müge Yirmibeşoğlu1, Sidita Vitoja1, Esat Çalık1, Cem Terzi2
1Dokuz Eylül Üniversitesi Tıp Fakültesi, İzmir, Türkiye
2Dokuz Eylül Üniversitesi Tıp Fakültesi, Genel Cerrahi AD, İzmir, Türkiye
Abstract
Aim: To discuss the diagnosis and treatment of superior vein thrombosis in a patient who has hereditary thrombophilia, to point out the importance of preventive treatment in these patients.
Materials and Methods: We investigated the whole peroperative period in a patient who underwent emergency surgical treatment for superior mesenteric vein thrombosis due to prothrombin 20210 G/A and MTHFR C677T mutations.
Results: We performed partial small bowel resection and primary anastomosis laparoscopically with the diagnosis of superior mesenteric vein thrombosis. Oral anticoagulation treatment was initiated at the postoperative period. The patient was discharged without any problem.
Conclusion: Although it is quite rare, prothrombin 20210 G/A and MTHFR C677T mutations may be found in Turkish population. In patients who have multiple thrombotic events, prothrombin 20210 G/A and MTHFR C677T mutations should be considered. Life-time oral anticoagulation therapy is important in these patients.
Keywords: Superior mesenteric vein thrombosis, prothrombin 20210 G/A mutation, methylenetetrahydrofolate reductase C677T mutation